role
respiratori
syncyti
viru
rsv
immunopathogenesi
incomplet
describ
assess
effect
primari
rsv
infect
transgen
mice
either
overexpress
lung
oe
nontransgen
litterm
nt
challeng
intranas
rsv
oe
mice
significantli
decreas
peak
viral
titer
four
day
infect
compar
nontransgen
litterm
addit
oe
mice
significantli
lower
rsvinduc
weight
loss
reduc
lung
ifng
protein
express
compar
nt
mice
contrast
primari
rsv
challeng
defici
mice
result
small
statist
signific
increas
viral
titer
day
four
infect
differ
rsvinduc
weight
loss
compar
wild
type
mice
augment
ifng
product
day
infect
ko
mice
primari
rsv
challeng
produc
high
level
product
lung
treatment
neutral
protein
result
greater
peak
viral
titer
four
six
day
rsv
greater
rsvinduc
weight
loss
compar
mice
treat
control
protein
result
suggest
modul
ill
rsvinfect
murin
model
suggest
import
mediat
enhanc
patholog
rsv
immun
strategi
use
either
recombin
vaccinia
viru
express
rsv
g
glycoprotein
formalininactiv
rsv
vaccin
mice
either
secret
rsv
g
glycoprotein
formalininactiv
alumprecipit
rsv
lead
immun
respons
character
augment
express
greater
ill
patholog
decreas
viral
clearanc
heighten
pulmonari
eosinophilia
subsequ
rsv
challeng
recent
data
group
reveal
block
activ
inhibit
formalininactiv
rsvinduc
immun
respons
suffici
rsv
g
glycoproteininduc
eosinophilia
rsv
challeng
howev
role
immun
respons
primari
rsv
challeng
fulli
describ
produc
type
lymphocyt
mast
cell
basophil
eosinophil
critic
cytokin
allerg
respons
interact
allerg
lung
inflamm
rsv
infect
caus
airway
dysfunct
great
import
clinic
medicin
addit
report
respons
rsvinduc
airway
hyperrespons
mani
immunomodulatori
properti
partli
cytokin
signal
receptor
achain
previous
group
found
significantli
delay
rsv
clearanc
associ
suppress
develop
virusspecif
cytotox
lymphocyt
suggest
might
similar
effect
howev
play
critic
role
immun
gastrointestin
nematod
nippostrongylu
brasiliensi
intracellular
parasit
leishmania
major
highlight
diverg
phenotyp
effect
cytokin
vivo
model
infect
given
function
similar
differ
sought
determin
contribut
immun
respons
primari
rsv
infect
experi
studi
rsv
infect
mice
overexpress
oe
airway
epithelium
mice
gene
delet
ko
background
also
examin
role
rsv
immun
administ
solubl
receptor
rsvinfect
knockout
ko
mice
balbc
background
rsv
infect
ko
mice
balbc
background
elicit
mix
respons
high
level
wild
type
balbc
mice
predomin
immun
respons
rsv
infect
high
level
interferon
ifn
g
extrem
low
undetect
level
comparison
immun
respons
three
differ
model
rsv
infect
reveal
elev
level
oe
mice
result
decreas
peak
viral
titer
protect
ill
decreas
lung
ifng
level
contrast
rsv
infect
ko
mice
ko
mice
administ
result
higher
peak
viral
tier
delay
clearanc
augment
ifng
product
lung
mice
week
old
pathogen
free
oe
mice
gener
previous
describ
bred
back
background
oe
mice
use
experi
heterozyg
oe
transgen
nontransgen
litterm
nt
use
control
oe
nt
maintain
water
transgen
activ
desir
time
doxycyclin
mgml
ad
anim
drink
water
sucros
also
ad
mask
bitter
tast
doxycyclin
four
day
treatment
doxycyclin
averag
level
ae
pgml
ground
lung
homogen
four
oe
mice
averag
level
ae
pgml
four
oe
mice
treat
vehicl
level
undetect
ground
lung
supernat
nt
whether
treat
doxycyclin
therefor
given
oe
produc
treat
doxycyclin
oe
nt
mice
treat
doxycyclin
avoid
confound
effect
doxycyclin
treatment
group
other
defici
ko
mice
gener
previous
describ
bred
back
background
wild
type
agematch
mice
purchas
jackson
laboratori
control
ko
mice
ko
mice
balbc
background
gener
previous
describ
wild
type
agematch
control
balbc
mice
purchas
charl
river
control
ko
mice
care
anim
investig
adher
guid
care
use
laboratori
anim
prepar
committe
care
use
laboratori
anim
institut
laboratori
anim
resourc
nation
research
council
revis
cell
maintain
eagl
minim
essenti
media
emem
supplement
glutamin
amphotericin
gentamicin
penicillin
g
fetal
bovin
serum
emem
strain
rsv
provid
dr
robert
chanock
nation
institut
health
master
stock
work
stock
rsv
prepar
previous
describ
construct
infram
fusion
extracellular
domain
murin
achain
domain
constant
region
human
heavi
chain
shown
specif
bind
neutral
effect
activ
reagent
appropri
isotyp
control
iggc
provid
sandi
goldman
wyeth
cambridg
experi
util
ko
mice
mice
inject
microgram
either
control
protein
day
day
mice
infect
rsv
given
mockinfect
cultur
media
mock
intranas
previous
describ
briefli
mice
anesthet
intramuscular
ketamin
mgg
xylazin
mgg
held
upright
neck
fulli
extend
mice
readili
inhal
ml
inoculum
stock
viru
place
nostril
micropipett
titer
pfu
rsv
use
experi
oe
ko
appropri
control
mice
titer
pfu
rsv
use
experi
ko
appropri
control
mice
titer
pfu
use
neutral
experi
use
wild
type
balbc
mice
rsv
infect
procedur
caus
bronchiol
pulmonari
infect
confirm
subset
mice
plaqu
assay
cell
previous
describ
lung
tissu
remov
weigh
immedi
quickfrozen
emem
briefli
one
lung
mous
harvest
ml
serum
free
media
lung
snap
frozen
later
thaw
ground
use
mortar
pestl
ground
glass
solut
ground
lung
ground
glass
centrifug
rpm
min
obtain
clarifi
lung
supernat
clarifi
lung
supernat
dilut
inocul
onto
subconflu
cell
monolay
costar
plate
costar
cambridg
h
plate
cover
methylcellulos
emem
incub
day
c
monolay
fix
buffer
formalin
stain
hematoxylineosin
plaqu
count
aid
dissect
microscop
level
ifng
ground
lung
supernat
see
paragraph
measur
use
commerci
avail
elisa
kit
r
system
minneapoli
mn
accord
manufactur
protocol
cytokin
level
lung
measur
duplic
mice
sacrif
lung
harvest
day
postinfect
lymphocyt
isol
manual
grind
lung
tissu
nylon
strainer
rpmi
lymphocyt
isol
centrifug
cushion
ficollhypaqu
room
temperatur
wash
resuspend
rpmi
plu
fb
lymphocyt
incub
h
mg
appropri
peptid
b
restrict
ctl
epitop
protein
correspond
amino
acid
naitnakii
ml
rpmi
plu
fb
mgml
costimulatori
ab
one
hour
incub
mgml
golgistop
bd
pharmingen
san
diego
ca
ad
retain
newli
synthes
protein
within
cell
cell
stimul
ngml
pma
mm
ionomycin
posit
control
mg
ovalbumin
peptid
correspond
amino
acid
ml
media
neg
control
incub
period
h
c
incub
cell
fix
permeabil
accord
manufactur
instruct
bd
pharmingen
san
diego
ca
cell
stain
fluorochromeconjug
ab
ifng
tnfa
bd
pharmingen
min
c
analyz
becton
dickenson
lsr
ii
cytomet
bd
bioscienc
san
jose
ca
equip
nm
argon
laser
nm
helium
neon
laser
data
analyz
use
bd
facsdiva
softwar
version
bd
bioscienc
fifth
day
infect
mice
sacrif
lung
lavag
fix
aliquot
ml
phosphat
buffer
salin
pb
equal
volum
fluid
ml
solubil
load
buffer
tri
ph
mm
dithiothreitol
bromophenol
blue
sodium
dodecyl
sulfat
sd
glycerol
c
min
protein
resolv
precast
trisglycin
polyacrylamid
gel
invitrogen
corp
carlsbad
ca
protein
resolut
gel
transfer
nitrocellulos
paper
incub
either
rabbitantihuman
spa
antibodi
dilut
follow
peroxidaseconjug
goat
antirabbit
igg
sigma
dilut
immunodetect
protein
detect
chemiluminesc
ecl
system
amersham
bioscienc
corp
piscataway
nj
record
highperform
chemiluminesc
film
quantiz
perform
use
imag
quantit
abil
imag
system
syngen
frederick
md
polyclon
igg
specif
surfact
proteina
rais
rabbit
inject
isol
human
spa
obtain
human
lung
lavag
kindli
provid
dr
cr
mendelson
southwestern
univers
dalla
texa
bal
fluid
obtain
describ
fifth
day
infect
nuncimmuno
maxisorp
plate
coat
ml
monoclon
antimous
spd
mgml
dilut
sodium
bicarbon
buffer
overnight
c
next
morn
well
empti
three
hundr
ml
per
well
blockingdilut
buffer
ad
well
h
blockingdilut
buffer
consist
tri
ph
sodium
chlorid
calcium
chlorid
vv
wv
bovin
serum
albumin
bsa
fraction
v
well
empti
ml
per
well
standard
nanogram
per
ml
sampl
dilut
blockingdilut
buffer
ad
plate
duplic
plate
place
rocker
incub
room
temperatur
h
incub
standard
sampl
aspir
well
wash
three
time
wash
buffer
consist
tri
ph
sodium
chlorid
calcium
chlorid
next
ml
per
well
dilut
blockingdilut
buffer
rabbit
antispd
ad
plate
incub
h
room
temperatur
rock
content
well
aspir
well
wash
three
time
wash
buffer
horseradish
peroxidas
conjug
donkey
antirabbit
igg
h
l
jackson
laboratori
bar
harbor
dilut
blockingdilut
buffer
ml
ad
well
h
incub
well
wash
three
time
wash
buffer
ml
tmb
biofx
laboratori
owe
mill
md
ad
well
plate
stop
color
develop
ml
h
optic
densiti
well
read
microtit
plate
reader
wavelength
namomet
blood
drawn
day
infect
centrifug
serum
retain
measur
rsvspecif
antibodi
measur
antirsvspecif
f
antibodi
titer
purifi
f
protein
dilut
bicarbon
buffer
ph
ad
plate
immulon
ii
nunc
roskild
denmark
mgwell
incub
overnight
c
coat
plate
empti
block
ml
bovin
serum
albumin
sigma
st
loui
mo
plate
wash
four
time
phosphatebuff
tween
serum
dilut
serum
uninfect
mous
use
neg
control
blank
one
hundr
ml
dilut
serum
ad
duplic
coat
well
plate
incub
room
temperatur
h
plate
wash
five
time
phosphatebuff
tween
wash
ml
horseradish
peroxidas
label
antimous
immunoglobulin
immunoglobulin
southern
biotech
birmingham
ala
ad
appropri
well
dilut
incub
h
room
temperatur
plate
wash
four
time
phosphatebuff
tween
wash
ml
conjug
solut
r
system
minneapoli
mn
ad
well
incub
h
c
plate
wash
four
time
phosphatebuff
salin
without
tween
reaction
stop
ml
n
h
optic
densiti
measur
filter
valu
calcul
standard
curv
result
express
mean
ae
standard
error
mean
sem
measur
weight
loss
curv
compar
anova
scheff
posthoc
analysi
measur
viral
titer
cytokin
compar
ttest
differ
consid
signific
p
weight
loss
measur
rsvinduc
diseas
correl
ill
score
determin
effect
overexpress
rsvinduc
weight
loss
day
intranas
challeng
two
group
mice
rsv
oersv
ntrsv
two
group
mockinfect
oemock
ntmock
shown
fig
differ
weight
loss
curv
oersv
oemock
ntmock
howev
nontransgen
litterm
control
ntrsv
mice
significantli
greater
weight
loss
three
group
p
therefor
oe
mice
significantli
protect
rsvinduc
weight
loss
oe
mice
decreas
peak
rsv
titer
enhanc
viral
clearanc
decreas
lung
ifng
product
order
determin
effect
overexpress
kinet
viral
replic
perform
plaqu
assay
day
fig
found
day
oersv
mice
significantli
decreas
peak
viral
titer
compar
nontransgen
litterm
control
ntrsv
mice
ae
vs
ae
log
pfug
lung
p
day
oersv
mice
significantli
decreas
viral
titer
compar
litterm
control
ntrsv
mice
ae
vs
ae
log
pfug
lung
p
therefor
overexpress
result
decreas
peak
viral
titer
enhanc
viral
clearanc
order
determin
effect
overexpress
cellular
immun
cytokin
respons
rsv
infect
measur
ifng
ground
lung
supernat
day
infect
fig
found
oersv
mice
significantli
decreas
ifng
compar
nontransgen
litterm
control
ntrsv
mice
ae
vs
ae
pgml
p
thu
overexpress
lung
profound
effect
rsv
pathogenesi
decreas
peak
rsv
titer
enhanc
viral
clearanc
decreas
lung
ifng
product
order
determin
effect
ill
result
rsv
infect
measur
weight
ko
wt
control
mice
either
mockinfect
rsvinfect
day
fig
found
rsvinfect
ko
rsvinfect
wt
mice
significantli
greater
weight
loss
compar
mockinfect
ko
mice
p
found
differ
weight
loss
rsvinfect
ko
rsvinfect
wt
mice
thu
defici
effect
degre
rsvinduc
weight
loss
order
determin
effect
defici
kinet
rsv
replic
perform
plaqu
assay
day
fig
found
day
korsv
mice
small
statist
signific
increas
peak
viral
titer
compar
wtrsv
mice
ae
vs
ae
log
pfug
lung
p
day
korsv
mice
trend
toward
increas
viral
titer
compar
wtrsv
mice
ae
vs
ae
log
pfug
lung
p
although
defici
result
increas
peak
viral
titer
statist
signific
biolog
relev
differ
less
log
uncertain
order
determin
effect
defici
cellular
immun
cytokin
respons
rsv
infect
measur
ifng
ground
lung
supernat
day
infect
fig
found
korsv
mice
significantli
increas
ifng
compar
litterm
control
wtrsv
mice
ae
vs
ae
pgml
p
thu
result
increas
peak
rsv
titer
augment
lung
ifng
product
oe
constitut
express
transgen
previous
report
exhibit
signific
increas
spa
spd
express
compar
nontransgen
litterm
sinc
saw
small
statist
signific
chang
peak
viral
titer
korsv
mice
compar
wtrsv
mice
sought
determin
differ
viral
titer
might
relat
defici
regul
lung
spa
spd
express
spa
spd
antivir
properti
measur
spa
spd
bronchoalveolar
lavag
fluid
found
differ
level
either
spa
spd
protein
wtmock
komock
group
wtrsv
korsv
group
mention
result
found
signific
reduct
viral
titer
oe
mice
compar
nt
mice
transgen
induc
doxycyclin
two
day
prior
rsv
infect
howev
find
differ
either
spa
spd
protein
level
bal
fluid
either
ntmock
oemock
ntrsv
oersv
group
therefor
differ
viral
titer
wt
ko
group
differ
viral
titer
nt
oe
group
like
relat
differ
spa
spd
express
mice
overexpress
defici
effect
number
rsvspecif
ifngexpress
cell
assess
affect
number
rsvspecif
ifngexpress
cell
measur
percentag
cell
produc
ifng
respons
newli
identifi
rsvspecif
b
restrict
ctl
epitop
result
list
percentag
ifngstain
cell
lymphocyt
gate
differ
peptidestimul
cell
express
ifng
either
oe
wt
mice
either
day
ae
vs
ae
respect
n
group
day
ae
vs
ae
respect
n
group
similarli
differ
peptidestimul
cell
express
ifng
either
ko
wt
mice
either
day
ae
vs
ae
respect
n
group
day
ae
vs
ae
respect
n
group
therefor
neither
overexpress
defici
appear
influenc
number
rsvspecif
ifngproduc
lymphocyt
examin
modul
rsvspecif
antibodi
titer
measur
antirsv
f
level
serum
day
primari
infect
differ
either
rsvspecif
nt
oe
mice
fig
panel
trend
toward
increas
p
rsvspecif
level
wt
mice
compar
ko
mice
differ
group
rsvspecif
level
fig
panel
b
therefor
neither
overexpress
defici
appear
influenc
rsvspecif
antibodi
titer
measur
day
primari
infect
ko
mice
lead
greater
weight
loss
express
induc
rsvinfect
ko
mice
previous
shown
ko
mice
greater
weight
loss
compar
wt
balbc
mice
infect
pfu
order
determin
effect
neutral
rsvinduc
ill
mice
administ
control
protein
iggc
intraperiton
prior
day
infect
fig
found
rsvinfect
ko
mice
treat
korsv
significantli
greater
weight
loss
p
compar
rsvinfect
ko
mice
treat
iggc
korsv
iggc
suggest
protect
effect
rsvinduc
weight
loss
ko
mice
sinc
korsv
mice
greater
weight
loss
korsv
iggc
group
determin
effect
viral
titer
two
group
fig
found
korsv
mice
significantli
greater
viral
titer
korsv
iggc
group
day
ae
vs
ae
log
pfug
lung
p
day
ae
vs
ae
log
pfug
lung
p
compar
korsv
iggc
mice
korsv
mice
greater
viral
titer
korsv
iggc
group
decid
measur
lung
level
ifng
two
group
fig
day
korsv
mice
increas
lung
ifng
level
korsv
iggc
ae
vs
ae
pgml
p
although
differ
statist
signific
howev
day
korsv
iggc
undetect
lung
level
ifng
korsv
mice
ae
pgml
p
therefor
result
indic
role
diminish
viral
titer
rsv
infect
decreas
lung
express
ifng
studi
investig
effect
overexpress
defici
product
neutral
use
solubl
receptor
immun
respons
primari
rsv
challeng
induc
overexpress
prior
rsv
infect
decreas
viral
titer
diminish
lung
ifng
product
protect
rsvinduc
weight
loss
contrast
mice
express
higher
viral
titer
increas
ifng
product
effect
rsvinduc
weight
loss
furthermor
administr
ko
mice
express
primari
rsv
challeng
lead
increas
viral
titer
prolong
ifng
express
greater
rsvinduc
weight
loss
experi
therefor
found
invers
relat
viral
titer
diminish
viral
antigen
load
probabl
abrog
need
strong
adapt
immun
respons
result
decreas
ifng
product
lung
absenc
increas
viral
load
yet
unknown
mechan
result
greater
requir
adapt
immun
clear
viru
henc
increas
lung
ifng
level
result
suggest
modul
immun
respons
rsv
infect
studi
examin
effect
viral
infect
vitro
studi
reveal
vari
effect
antivir
immun
depend
viru
studi
primari
bloodderiv
human
macrophag
expos
decreas
infect
replic
block
complet
revers
transcript
thu
decreas
viru
product
diminish
infect
progeni
viru
addit
induc
reduct
number
bind
site
complet
inhibit
surfac
express
hiv
receptor
coreceptor
known
receptor
rsv
also
protect
bronchoalveolar
macrophag
product
infect
product
strongli
inhibit
alveolar
macrophag
treat
treatment
increas
human
cytomegaloviru
express
cell
examin
two
vivo
murin
model
rsv
infect
tekkanat
lukac
report
primari
rsv
infect
balbc
mice
induc
express
supernat
lung
homogen
studi
clinic
isol
univers
michigan
use
strain
use
clinic
isol
rsvinduc
associ
airway
hyperrespons
airway
epitheli
mucu
product
featur
block
administr
antibodi
investig
also
found
rsvinfect
mice
treat
antibodi
significantli
reduc
viral
antigen
level
lung
homogen
measur
elisa
specif
rsv
protein
measur
pfu
studi
also
measur
effect
ifng
product
contrast
park
colleagu
found
rsv
infect
caus
airway
hyperrespons
independ
studi
use
human
rsv
long
strain
type
purifi
sucros
gradient
experi
use
two
protocol
one
examin
ko
mice
balbc
background
anoth
use
wild
type
balbc
mice
reagent
use
studi
investig
also
found
rsv
induc
airway
epitheli
mucu
product
absent
ko
mice
inhibit
wild
type
mice
treat
neither
viral
titer
ifng
measur
experi
studi
unabl
detect
primari
rsv
strain
infect
wild
type
balbc
mice
either
measur
protein
ground
lung
homogen
lung
mrna
rnase
protect
assay
found
airway
hyperrespons
rsvinfect
mice
differ
studi
tekkanat
lukac
park
group
may
explain
differ
rsv
strain
util
prepar
viru
stock
dose
rout
administr
mechan
airway
respons
measur
collabor
lukac
group
recent
report
differenti
immun
respons
pulmonari
pathophysiolog
induc
two
differ
strain
respiratori
syncyti
viru
induc
similar
biolog
function
stem
fact
chain
share
receptor
trigger
signal
pathway
howev
cell
express
receptor
effect
mediat
directli
cytokin
cell
effector
may
differ
studi
tumor
surveil
suggest
may
alter
cell
function
intermedi
cell
type
cytolyt
function
also
increas
inhibit
set
recombin
vaccinia
infect
viru
titer
ill
report
shown
increas
virul
poxviru
infect
associ
reduct
ctl
precursor
frequenc
also
shown
influenc
ctl
respons
rsv
overexpress
rsv
infect
result
delay
viru
clearanc
enhanc
ill
associ
abrog
cytolyt
cell
activ
effect
cell
function
set
relat
alter
cytolyt
function
alter
frequenc
ifng
product
cell
current
studi
clearli
show
serv
protect
role
rsv
infect
alter
frequenc
ifng
produc
cell
rsvspecif
cytolyt
activ
measur
rapid
viru
clearanc
fig
suggest
cell
function
intact
differ
effect
biolog
function
ctl
consequ
impact
viru
pathogenesi
like
due
differ
specif
receptor
distribut
differ
pattern
cell
activ
mechan
protect
rsvinduc
weight
loss
oe
mice
experi
use
ko
mice
still
unclear
constitut
express
transgen
oe
mice
increas
surfact
protein
sp
b
c
twofold
spd
increas
level
found
nontransgen
litterm
found
differ
surfact
protein
oe
mice
transgen
induc
two
day
prior
rsv
infect
nt
mice
relev
model
spa
spd
collectin
enhanc
pulmonari
clearanc
rsv
also
found
defici
alter
either
spa
spd
level
bal
fluid
therefor
surfact
regul
rsv
replic
seem
explan
regulatori
effect
rsvinduc
immun
respons
possibl
mechan
may
modul
rsv
pathogenesi
includ
regul
matrix
andor
cathepsin
lung
express
induc
oe
mice
enhanc
syncyti
format
lead
rsv
multipl
spread
effect
blunt
mmp
inhibitor
therefor
would
suggest
induc
turn
would
increas
viral
titer
howev
studi
found
overexpress
reduc
viral
titer
defici
increas
viral
titer
thu
clear
interact
regul
might
play
role
viral
replic
vivo
studi
also
induc
express
cathepsin
major
factor
endosom
lysosom
system
proteas
critic
intracellular
antigen
process
present
cathepsin
shown
essenti
murin
coronaviru
mous
hepat
viru
type
spikemedi
entri
also
enhanc
entri
mediat
ebola
viru
glycoprotein
howev
role
cathepsin
rsv
entri
pathogenesi
describ
summari
found
overexpress
protect
rsvinduc
weight
loss
decreas
viral
titer
lung
ifng
product
hand
defici
result
increas
viral
titer
lung
ifng
product
neutral
ko
mous
induc
primari
rsv
challeng
result
enhanc
weight
loss
increas
viral
titer
lung
ifng
product
result
reveal
significantli
modul
rsvinduc
diseas
